These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1292420)

  • 1. Calcitriol injection for the management of renal osteodystrophy.
    Peacock E
    ANNA J; 1992 Dec; 19(6):575-7. PubMed ID: 1292420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure.
    Andress DL; Norris KC; Coburn JW; Slatopolsky EA; Sherrard DJ
    N Engl J Med; 1989 Aug; 321(5):274-9. PubMed ID: 2631697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of secondary hyperparathyroidism during oral calcitriol therapy in pediatric renal osteodystrophy.
    Goodman WG; Salusky IB
    Contrib Nephrol; 1991; 90():189-95. PubMed ID: 1959345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal osteodystrophy in dialyzed children.
    Salusky IB; Goodman WG
    Miner Electrolyte Metab; 1991; 17(4):273-80. PubMed ID: 1813790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of oral and parenteral calcitriol in the treatment of renal osteodystrophy.
    Coburn JW
    Kidney Int Suppl; 1990 Sep; 29():S54-61. PubMed ID: 2214548
    [No Abstract]   [Full Text] [Related]  

  • 7. Low-dose vitamin D analogues for renal osteodystrophy.
    Lancet; 1989 Jun; 1(8651):1364-5. PubMed ID: 2567378
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of renal osteodystrophy with calcitriol in patients on maintenance haemodialysis].
    Tomanovski V
    Srp Arh Celok Lek; 1994; 122(5-6):136-8. PubMed ID: 17977409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D compounds and renal osteodystrophy.
    Felsenfeld AJ; Llach F
    Int J Artif Organs; 1983 Nov; 6(6):281-4. PubMed ID: 6689416
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of 1,25-dihydroxyvitamin D3 in early renal failure.
    Goodman WG; Coburn JW
    Annu Rev Med; 1992; 43():227-37. PubMed ID: 1580587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous versus oral calcitriol therapy in renal osteodystrophy: results of a prospective, pulsed and dose-comparable study.
    Mazzaferro S; Pasquali M; Ballanti P; Bonucci E; Di Sanza P; Sardella D; Taggi F; Coen G
    Miner Electrolyte Metab; 1994; 20(3):122-9. PubMed ID: 7816000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous versus oral calcitriol therapy: is there a clinical difference?
    Lantz JP
    Nephrol News Issues; 1992 Sep; 6(9):38-41. PubMed ID: 1407072
    [No Abstract]   [Full Text] [Related]  

  • 13. Pulse dose oral calcitriol therapy for renal osteodystrophy: literature review and practice recommendations.
    Dahl NV; Foote EF
    ANNA J; 1997 Oct; 24(5):550-5. PubMed ID: 9392738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal osteodystrophy.
    Malluche HH; Faugere MC
    N Engl J Med; 1989 Aug; 321(5):317-9. PubMed ID: 2747771
    [No Abstract]   [Full Text] [Related]  

  • 15. Renal bone disease in pediatric patients receiving treatment with maintenance peritoneal dialysis.
    Salusky IB; Goodman WG
    Child Nephrol Urol; 1991; 11(3):165-8. PubMed ID: 1777895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marked improvement in parameters of renal osteodystrophy with the use of intraperitoneal calcitriol.
    Arora N; Sandroni S; Moles K
    Adv Perit Dial; 1992; 8():62-4. PubMed ID: 1361854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone and calcitriol as modifiers of bone formation in renal osteodystrophy.
    Salusky IB; Goodman WG
    Kidney Int; 1995 Sep; 48(3):657-65. PubMed ID: 7474649
    [No Abstract]   [Full Text] [Related]  

  • 18. Calcitriol, lanthanum carbonate, and other new phosphate binders in the management of renal osteodystrophy.
    Hutchison AJ
    Perit Dial Int; 1999; 19 Suppl 2():S408-12. PubMed ID: 10406555
    [No Abstract]   [Full Text] [Related]  

  • 19. [Course and significance of various biochemical parameters in 1,25-dihydroxyvitamin D3 therapy of uremic osteodystrophy].
    Giachino G; Giacchino F; Basolo B; Giraudo G; Boero R; Bancale E; Nigra M; Garetto A; Jeantet A; Piccoli G
    Arch Sci Med (Torino); 1983; 140(3):259-66. PubMed ID: 6689545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of treatments for mild secondary hyperparathyroidism in hemodialysis patients. Durham Renal Osteodystrophy Study Group.
    Indridason OS; Quarles LD
    Kidney Int; 2000 Jan; 57(1):282-92. PubMed ID: 10620210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.